Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
9,630
NCT01661725
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2006
Completion: May 31, 2006
NCT01554813
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)
Phase: Phase 3
Start: May 31, 2006
Completion: Oct 31, 2006
NCT01661738
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002
Phase: Phase 2
Completion: Jun 30, 2006
NCT01661751
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
Completion: Aug 31, 2006
NCT01568788
Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine
Phase: N/A
Start: Dec 31, 2008
Completion: Mar 31, 2009
NCT01554826
Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)
Start: Mar 31, 2009
Completion: Feb 28, 2010
NCT01511744
Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine
Phase: Phase 4
Start: Nov 30, 2011
Completion: Mar 31, 2012